Managing pregnant patients: Which in-person and virtual visits are necessary

A study highlights the rise of hybrid prenatal care during the COVID-19 public health emergency, though telehealth's potential remains underutilized across racial and geographic groups.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

The findings of the study suggest HS is associated with pregnancy complications and adverse outcomes for both mothers and offspring.

On this episode of Pap Talk, Emily Adhikari, MD answers frequently asked questions about the COVID-19 vaccine.

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

In a recent study, very preterm birth rates were reduced during COVID-19 lockdown periods vs prepandemic periods.